SMNR and SRNEQ Related Headlines

Go Back

Jul 7, 2026 06:00AM Semnur signs $100M binding term sheet with Kazakhstan investor

Jul 7, 2026 06:00AM Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat

SMNR and SRNEQ Related Press Releases

Go Back

Jul 7, 2026 06:00AM Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat

SMNR and SRNEQ Related SEC Filings

Go Back

Jul 7, 2026 10:49AM Form 424B3 Semnur Pharmaceuticals,

Jul 7, 2026 10:41AM Form 8-K Semnur Pharmaceuticals, For: Jul 03

Jul 1, 2026 06:06AM Form 424B3 Semnur Pharmaceuticals,

Jun 26, 2026 04:24PM Form SCHEDULE 13D/A Semnur Pharmaceuticals, Filed by: Scilex Holding Co

Jun 26, 2026 04:20PM Form 4 Semnur Pharmaceuticals, For: Jun 15 Filed by: Scilex Holding Co

Jun 25, 2026 05:04PM Form 8-K Semnur Pharmaceuticals, For: Jun 25

Jun 15, 2026 05:02PM Form 424B3 Semnur Pharmaceuticals,

Jun 15, 2026 07:00AM Form 424B3 Semnur Pharmaceuticals,